Literature DB >> 15955326

The Entamoeba histolytica Ehcp112 gene has a distal and weak promoter.

E Flores-Soto1, E Azuara-Liceaga, C López-Camarillo, E Orozco.   

Abstract

Ehcp112 encodes the Entamoeba histolytica EhCP112 cysteine protease that is part of the EhCPADH complex. By in silico analysis we identified putative transcription factor-binding sites along 837 bp upstream the Ehcp112 gene ATG codon. A TATA-like motif (TATATAAA) was located at -36 to -29 bp, a GAAC box (GAACC) was found at -10 to -14 bp and an Inr sequence (TTCAAC) at -8 to -2 bp. These tripartite promoter elements are in non-canonical positions, downstream the transcription initiation site (-280 bp). We cloned four Ehcp112 promoter fragments in pBSCAT-ACT plasmid to obtain pI (355 bp), pII (681 bp), pIII (833 bp), and pIV (554 bp) constructs. In transfected trophozoites, only pIII drove CAT activity with 44% efficiency in relation to actin promoter activity. Our results showed the presence of a distal and weak promoter in the Ehcp112 gene. The active DNA region is inside the open reading frame of the Ehrab B gene, suggesting that expression of both genes could be coordinately regulated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955326     DOI: 10.1016/j.exppara.2005.03.003

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  3 in total

Review 1.  Regulation of gene expression in protozoa parasites.

Authors:  Consuelo Gomez; M Esther Ramirez; Mercedes Calixto-Galvez; Olivia Medel; Mario A Rodríguez
Journal:  J Biomed Biotechnol       Date:  2010-03-02

2.  Transferrin regulates mRNA levels of a gene involved in iron utilization in Entamoeba histolytica.

Authors:  Cristhian Sánchez-Cruz; Mavil López-Casamichana; Areli Cruz-Castañeda; José de Jesús Olivares-Trejo
Journal:  Mol Biol Rep       Date:  2011-09-27       Impact factor: 2.316

3.  Structural and functional analysis of the Entamoeba histolytica EhrabB gene promoter.

Authors:  Mónica Romero-Díaz; Consuelo Gómez; Israel López-Reyes; Máximo B Martínez; Esther Orozco; Mario A Rodríguez
Journal:  BMC Mol Biol       Date:  2007-09-20       Impact factor: 2.946

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.